Novo Nordisk reports data breach, tells clinical trial patients to ‘remain vigilant’

Novo Nordisk reported a security breach affecting internal IT systems in which a limited amount of de‑identified information related to some clinical trial participants (e.g., year of birth, biomarkers, lifestyle factors) was copied externally without authorization; the company stated no direct identifiers were exposed.